Help Parkinson's research move further!

Be part of clinical research studies near you evaluating investigational drugs to see if they may help improve PD symptoms that impact your movement and daily activities.


Residential Care Facility Presentation

 July 18, 2024 at 3 PM


Learn about active clinical trials, how you can help, and what's in it for you

Guide to Participating in Parkinsons Clinica Trials
Let's connect
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Participate in Parkinson's Research Studies

Our goal at SC3 Research is to advance the discovery of treatments for neurodegenerative disorders like Parkinson's Disease. We are researching Parkinson’s treatments where it matters the most. 

Slowing Parkinson's Progression
Join a Phase 2 trial evaluating an oral medication designed to potentially slow the progression of Parkinson's disease.
Managing Parkinson's Motor Fluctuations
Help our researchers investigate a potential new treatment. This Phase 2 study explores its ability to improve "On/Off" time symptoms and movement control in advanced Parkinson's.

Why Are These Studies Important

There is an urgent need for safe and effective treatments that can improve motor fluctuation symptoms (on/off time) and slow the progression of Parkinson's Disease. Clinical trials help to determine if treatments and other interventions are safe and effective. Studies enrolling diverse populations are monitored to ensure that the rights and safety of all participants are protected. Without the participation of people with PD, it would be impossible to develop new and better solutions.

Why you should participate

Access to Parkinson's study treatment
Close care and monitoring from Parkinson's specialists.
The opportunity to help advance the treatment of Parkinson's disease.
Reimbursement for study-related time and travel expenses.

If you decide to join this study, your health and safety will carefully be monitored by specialists, and your participation will help doctors evaluate the study drugs to measure their effectiveness. 

Further details regarding our clinical studies

We are evaluating the efficacy and safety of the Parkinson's investigational drug in three different groups of patients:

People with early stage PD
(diagnosis within the past 3 years) who are not currently taking levodopa or dopamine agonists to manage symptoms
People who are currently taking levodopa
Parkinson's patients who are currently taking levodopa to manage OFF-TIME symptoms
People with untreated Parkinson's
Our goal is to change the trajectory of this condition, offering hope and improved outcomes for those facing a recent diagnosis.

If you or someone you love are interested to learn or participate in Parkinson's clinical studies, please click the button below. 


Parkinson’s Explorers Support Group Presentation

  Saturday, February 10, 2024

 Alexander Hughes Community Center, 1700 Danbury Rd, Claremont, CA 91711, USA

Check out some snaps from previous PD community events. 

You can advance Parkinson's research

Sign up to learn more about clinical trials.
Along with the PD research community, we are committed to finding solutions for everyone affected by Parkinson's disease— the very people who hold the key to the answers. Without participants in research studies, Parkinson's disease research would come to a standstill.

Clinical research site locations near you

SC3 Research Group, Inc. has clinical research site locations at Pasadena and Reseda.

SC3 Research Group, Inc - Pasadena

Phone: (626) 250-2070

Address: 50 BELLEFONTAINE ST., STE 203, PASADENA, CA 91105